Efficacy of Extracorporeal Shock Wave Therapy (ESWT) on Cervical Myofascial Pain Following Neck Dissection Surgery
Overview
- Phase
- N/A
- Intervention
- extra-corporeal shock wave therapy
- Conditions
- Pain
- Sponsor
- Qassim University
- Enrollment
- 46
- Locations
- 1
- Primary Endpoint
- Visual analogue scale
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Myofascial pain syndrome (MPS) is a musculoskeletal disorder which is characterized by pain, muscle spasms and muscle tenderness, as well as a limited range of motion, weakness, and rarely, autonomous dysfunction.
Detailed Description
The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome through elimination of ischemia and modulation of vasoneuroactive substance (two major causes of trigger pathophysiology) and mechanical transduction as a cellular response to external stimulation. the aim of this study was to investigate efficacy of extracorporeal shock wave therapy (ESWT) on cervical myofascial pain following neck dissection surgery.
Investigators
Maged Basha
Assistant Professor, Department of Physical Therapy, College of Medical Rehabilitation, Qassim University, Saudi Arabia, Qassim, Buraidah.
Qassim University
Eligibility Criteria
Inclusion Criteria
- •Previous unilateral modified radical neck dissection.
- •Patients with myofascial pain of upper trapezius for at least 3 months.
- •Patients with palpable intramuscular taut band.
- •Restriction in cervical ROM of lateral flexion and rotation.
- •Provocation of the clinical symptoms by compression of the active trigger point
Exclusion Criteria
- •Patient who received medication or other therapies for MPS within the previous 2 months.
- •Patients with pacemaker, pregnancy
- •Open wound at the treatment area.
- •Cervical myelopathy or radiculopathy, cervical spine fracture or spondylolisthesis.
- •Rheumatoid arthritis.
- •Coagulopathy.
- •Epilepsy or any psychological disorder.
Arms & Interventions
ESWT Group
received ESWT once a week for 4 weeks (0.25 ml/mm2, 1000 shocks) plus topical none steroidal anti-inflammatory drug (NSAID; 3 times /day for 4 weeks).
Intervention: extra-corporeal shock wave therapy
control group
received only topical NSAID.
Intervention: topical none steroidal anti-inflammatory drug
Outcomes
Primary Outcomes
Visual analogue scale
Time Frame: after 4 weeks of treatment
VAS was utilized for assessing and quantifying pain exhibited by the patients through a 0-10 cm scale. Each subject was informed to mark the line according to the pain intensity experienced at that particular time where '0' means no pain and '10' means worst conceivable pain.
Secondary Outcomes
- Cervical range of motion assessment(after 4 weeks of treatment)